GlaxoSmithKline Consumer Healthcare Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Dec' 19	Sep' 19	Jun' 19	Mar' 19	Dec' 18

Sales

1,158.86

1,345.09

1,194.32

1,286.06

1,116.82

Operating profit

272.08

395.81

280.40

318.48

238.53

Interest

1.49

1.78

1.70

0.20

0.21

Gross profit

386.63

472.16

405.28

441.17

362.57

EPS (Rs)

65.77

82.10

58.98

67.95

52.56

Other income

116.04

78.13

126.58

122.89

124.25

Stock adjustment

-22.17

-4.34

22.59

-0.10

-68.36

Raw material

349.54

364.40

309.86

360.68

360.44

Power and fuel

-

-

-

-

-

Employee expenses

151.71

159.30

184.25

164.83

156.72

Excise

-

-

-

-

-

Admin and selling expenses

142.92

139.66

142.69

190.86

134.90

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

264.78

290.26

254.53

251.31

294.59

Provisions made

-

-

-

-

-

Depreciation

19.17

20.33

19.62

14.92

15.81

Taxation

90.83

106.52

137.58

140.44

125.70

Net profit / loss

276.63

345.31

248.08

285.81

221.06

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

42.06

42.06

42.06

42.06

42.06

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

23.48

29.43

23.48

24.76

21.36

GPM (%)

30.33

33.18

30.68

31.31

29.21

NPM (%)

21.70

24.26

18.78

20.29

17.81